ProfileGDS4718 / 201341_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 87% 75% 85% 84% 93% 96% 87% 87% 83% 86% 83% 97% 93% 97% 88% 87% 95% 96% 93% 82% 84% 85% 84% 84% 98% 91% 91% 88% 96% 96% 98% 88% 83% 96% 95% 93% 84% 86% 75% 83% 96% 98% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7710487
GSM549102patient 115, normal, homogenized [OPG study]8.647887
GSM549104patient 119, normal, homogenized [OPG study]7.4039675
GSM549108patient 138, normal, homogenized [OPG study]8.4035685
GSM549119patient 077, normal, homogenized [OPG study]8.2421384
GSM549133patient 032, cancer, homogenized [OPG study]9.8791293
GSM549139patient 042, cancer, homogenized [OPG study]10.392796
GSM549099patient 107, normal, homogenized [OPG study]8.6188487
GSM549109patient 139, normal, homogenized [OPG study]8.7123187
GSM549110patient 046, normal, homogenized [OPG study]8.1880183
GSM549114patient 063, normal, homogenized [OPG study]8.7029886
GSM549122patient 082, normal, homogenized [OPG study]8.2064483
GSM549134patient 033, cancer, homogenized [OPG study]10.731697
GSM549136patient 036, cancer, homogenized [OPG study]9.8862493
GSM549140patient 044, cancer, homogenized [OPG study]10.664197
GSM549111patient 047, normal, homogenized [OPG study]8.9198788
GSM549113patient 057, normal, homogenized [OPG study]8.8725987
GSM549132patient 031, cancer, homogenized [OPG study]10.122295
GSM549137patient 038, cancer, homogenized [OPG study]10.371596
GSM549142patient 047, cancer, homogenized [OPG study]9.3508193
GSM549100patient 110, normal, homogenized [OPG study]7.9915982
GSM549107patient 135, normal, homogenized [OPG study]8.4189484
GSM549115patient 068, normal, homogenized [OPG study]8.5859885
GSM549116patient 072, normal, homogenized [OPG study]8.4084684
GSM549120patient 078, normal, homogenized [OPG study]8.2865584
GSM549131patient 030, cancer, homogenized [OPG study]11.366298
GSM549118patient 074, normal, homogenized [OPG study]9.4637591
GSM549129patient 027, cancer, homogenized [OPG study]9.2570491
GSM549123patient 088, normal, homogenized [OPG study]8.8443988
GSM549124patient 006, cancer, homogenized [OPG study]10.267696
GSM549126patient 015, cancer, homogenized [OPG study]10.34596
GSM549128patient 025, cancer, homogenized [OPG study]11.148198
GSM549103patient 117, normal, homogenized [OPG study]8.7650988
GSM549117patient 073, normal, homogenized [OPG study]8.2595783
GSM549138patient 041, cancer, homogenized [OPG study]10.449896
GSM549141patient 045, cancer, homogenized [OPG study]10.166195
GSM549130patient 028, cancer, homogenized [OPG study]9.6256693
GSM549101patient 111, normal, homogenized [OPG study]8.2474584
GSM549105patient 128, normal, homogenized [OPG study]8.5434586
GSM549106patient 134, normal, homogenized [OPG study]7.4522975
GSM549112patient 048, normal, homogenized [OPG study]8.1949283
GSM549125patient 011, cancer, homogenized [OPG study]10.340396
GSM549127patient 024, cancer, homogenized [OPG study]11.077998
GSM549135patient 035, cancer, homogenized [OPG study]10.654196